Literature DB >> 3998109

Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella.

P Lebon, F Daffos, A Checoury, L Grangeot-Keros, F Forestier, J E Toublanc.   

Abstract

In congenital rubella an acid-labile alpha-interferon was present in sera collected from fetuses between weeks 21 and 29 of gestation and from children with active congenital rubella. This interferon was different from the interferon detected in normal amniotic fluid and was not found in sera from uninfected fetuses or from children with postnatally acquired rubella. The fetal interferon is of interest as a complementary marker to confirm the virus contamination of the fetuses during maternal rubella. The role of the prolonged synthesis of this interferon in congenital rubella disease and its immune defects are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998109      PMCID: PMC271779          DOI: 10.1128/jcm.21.5.775-778.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Immune deficiency in congenital rubella and other viral infections.

Authors:  M A South; J R Montgomery; W E Rawls
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Prolongation of allograft survival in mice by inducers of interferon.

Authors:  L E Mobraaten; E De Maeyer; J De Maeyer-Guignard
Journal:  Transplantation       Date:  1973-11       Impact factor: 4.939

3.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

4.  The immunoglobulins in congenital rubella.

Authors:  J F Soothill; K Hayes; J A Dudgeon
Journal:  Lancet       Date:  1966-06-25       Impact factor: 79.321

Review 5.  Congenital rubella: the significance of virus persistence.

Authors:  W E Rawls
Journal:  Prog Med Virol       Date:  1968

6.  Congenital rubella syndrome with immunoglobulin disorder.

Authors:  M P Hancock; C C Huntley; J L Sever
Journal:  J Pediatr       Date:  1968-05       Impact factor: 4.406

7.  Correlation of lymphocyte transformation and morphology in the human fetal thymus.

Authors:  M Papiernik
Journal:  Blood       Date:  1970-10       Impact factor: 22.113

8.  Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice.

Authors:  Y Rivière; I Gresser; J C Guillon; M G Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

9.  Interferon production in lymphocyte cultures after rubella infection in humans.

Authors:  E Buimovici-Klein; K E Weiss; L Z Cooper
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  6 in total

Review 1.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Presence of gamma interferon in human acute and congenital toxoplasmosis.

Authors:  J Raymond; M H Poissonnier; P H Thulliez; F Forestier; F Daffos; P Lebon
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

4.  Specific and non-specific serological markers in the screening for congenital CMV infection.

Authors:  A el-Mekki; L V Deverajan; S Soufi; O Strannegard; W al-Nakib
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

Review 5.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

6.  In vivo study of interferon-alpha-secreting cells in pig foetal lymphohaematopoietic organs following in utero TGEV coronavirus injection.

Authors:  I Splíchal; Z Reháková; M Sinkora; J Sinkora; I Trebichavský; H Laude; B Charley
Journal:  Res Immunol       Date:  1997-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.